|
FARSB expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.024270E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.271870E-02 |
| Normal-vs-Stage2 |
1.200190E-01 |
| Normal-vs-Stage3 |
7.618200E-01 |
| Normal-vs-Stage4 |
1.941550E-02 |
| Stage1-vs-Stage2 |
8.784400E-01 |
| Stage1-vs-Stage3 |
6.514200E-02 |
| Stage1-vs-Stage4 |
2.066800E-01 |
| Stage2-vs-Stage3 |
2.053000E-01 |
| Stage2-vs-Stage4 |
3.338000E-01 |
| Stage3-vs-Stage4 |
3.750000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.131550E-02 |
| Normal-vs-AfricanAmerican |
1.722160E-01 |
| Normal-vs-Asian |
6.530600E-01 |
| Caucasian-vs-AfricanAmerican |
7.248600E-01 |
| Caucasian-vs-Asian |
7.621800E-01 |
| AfricanAmerican-vs-Asian |
8.011600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.538770E-01 |
| Normal-vs-Female |
1.786850E-04 |
| Male-vs-Female |
1.014430E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.334400E-01 |
| Normal-vs-Age(41-60Yrs) |
9.480400E-02 |
| Normal-vs-Age(61-80Yrs) |
3.236600E-03 |
| Normal-vs-Age(81-100Yrs) |
4.568200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.519800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.932800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.178400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.976400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.601200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.876200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.728400E-01 |
| Normal-vs-Grade 2 |
5.438000E-03 |
| Normal-vs-Grade 3 |
1.475390E-01 |
| Normal-vs-Grade 4 |
7.914300E-02 |
| Grade 1-vs-Grade 2 |
4.208400E-01 |
| Grade 1-vs-Grade 3 |
7.287600E-01 |
| Grade 1-vs-Grade 4 |
2.349600E-01 |
| Grade 2-vs-Grade 3 |
1.451600E-01 |
| Grade 2-vs-Grade 4 |
6.081400E-01 |
| Grade 3-vs-Grade 4 |
2.535800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.84250000000641E-05 |
| Normal-vs-ccB subtype |
9.583800E-01 |
| ccA subtype-vs-ccB subtype |
1.406480E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.974400E-02 |
| Normal-vs-N1 |
2.150000E-01 |
| N0-vs-N1 |
3.946200E-01 |
|
|
